Autolus Therapeutics PLC (AUTL)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -73.435 | -21.578 | -21.216 | -42.948 | -47.541 | -40.611 | -33.229 | -48.145 |
Return on Equity (%) | -81.794 | -22.768 | -22.484 | -48.539 | -61.133 | -54.302 | -48.641 | -101.614 |
Return on Invested Capital (%) | -81.613 | -22.752 | -25.218 | -47.69 | -60.287 | -57.06 | -49.906 | -116.027 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -10941.141 | -2254.795 | -9619.258 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -9429.064 | -2402.954 | -12272.261 |
Book Value Per Share | 0.692 | 1.494 | 1.232 | 1.202 | 0.957 | 1.215 | 0.652 | 0.327 |
Earnings Per Share | -0.283 | -0.207 | -0.216 | -0.585 | -0.648 | -0.551 | -0.325 | -0.611 |
Cash Per Share | 0.633 | 1.436 | 1.193 | 0.994 | 0.699 | 1.204 | 0.835 | 0.703 |
Working Capital Per Share | 0.636 | 1.44 | 1.17 | 1.058 | 0.745 | 1.235 | 0.829 | 0.676 |
Operating Profit Per Share | 0.027 | 0.018 | 0.007 | 0.014 | 0.008 | 0.009 | 0.014 | 0.005 |
EBIT Per Share | -0.323 | -0.245 | -0.251 | -0.656 | -0.758 | -0.644 | -0.325 | -0.611 |
EBITDA Per Share | -0.323 | -0.245 | -0.251 | -0.656 | -0.758 | -0.644 | -0.325 | -0.611 |
Free Cash Flow Per Share | -0.252 | -0.187 | -0.178 | -0.518 | -0.607 | -0.55 | -0.318 | -0.598 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 15,69M | 17,43M | 40,15M | 44,98M | 52,35M | 90,91M | 290,91M | 174,1M |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 290,91M | 173,07M | 173,68M | N/A | 174,1M | 173,08M | 174,1M | 266,12M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -3008.978 | N/A | N/A | N/A | -331.275 | N/A | N/A |
Net Profit Margin (%) | N/A | -3081.347 | N/A | N/A | N/A | -522.148 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 763,77M |
Ratio cours/bénéfice | -3,69 |
Ratio prix/ventes | 451,56 |
Ratio prix/liquidités | 3,21 |
Ratio prix/valeur comptable | 6,9 |
Rendement de dividende | - |
Actions en circulation | 266,12M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales